20.01 USD
+0.03 (+0.15%)
20.01 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 87% to FMTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 21.01. This target is 5.01% above the current price.
FMTX was analyzed by 12 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about FMTX.
In the previous month the buy percentage consensus was at a similar level.
FMTX was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-09-02 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2022-09-02 | Credit Suisse | Downgrade | Outperform -> Neutral |
| 2022-09-02 | Jefferies | Downgrade | Buy -> Hold |
| 2022-09-02 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2022-05-27 | SVB Leerink | Maintains | Outperform |
| 2021-11-12 | SVB Leerink | Maintains | Outperform |
| 2021-08-17 | HC Wainwright & Co. | Maintains | Buy |
| 2021-08-02 | Craig-Hallum | Initiate | Buy |
| 2021-06-11 | SVB Leerink | Maintains | Outperform |
| 2021-03-31 | HC Wainwright & Co. | Maintains | Buy |
FORMA THERAPEUTICS HOLDINGS / FMTX FAQ
What do analysts expect the price target to be for FORMA THERAPEUTICS HOLDINGS (FMTX)?
12 analysts have analysed FMTX and the average price target is 21.01 USD. This implies a price increase of 5.01% is expected in the next year compared to the current price of 20.01.
Can you provide the consensus rating for FORMA THERAPEUTICS HOLDINGS stock?
The consensus rating for FORMA THERAPEUTICS HOLDINGS (FMTX) is 75 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed FORMA THERAPEUTICS HOLDINGS (FMTX)?
The number of analysts covering FORMA THERAPEUTICS HOLDINGS (FMTX) is 12.